Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Amortization - Intangibles (2016 - 2018)

Historic Amortization - Intangibles for Celldex Therapeutics (CLDX) over the last 9 years, with Q1 2018 value amounting to $224000.0.

  • Celldex Therapeutics' Amortization - Intangibles changed 0.0% to $224000.0 in Q1 2018 from the same period last year, while for Dec 2018 it was $224000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $224000.0 for FY2018, which is 7500.0% down from last year.
  • Latest data reveals that Celldex Therapeutics reported Amortization - Intangibles of $224000.0 as of Q1 2018, which was down 0.0% from $224000.0 recorded in Q4 2017.
  • In the past 5 years, Celldex Therapeutics' Amortization - Intangibles ranged from a high of $254000.0 in Q2 2014 and a low of $224000.0 during Q1 2017
  • In the last 5 years, Celldex Therapeutics' Amortization - Intangibles had a median value of $253000.0 in 2014 and averaged $243882.4.
  • As far as peak fluctuations go, Celldex Therapeutics' Amortization - Intangibles changed by 0.0% in 2014, and later tumbled by 1181.1% in 2017.
  • Celldex Therapeutics' Amortization - Intangibles (Quarter) stood at $253000.0 in 2014, then changed by 0.0% to $253000.0 in 2015, then dropped by 6.32% to $237000.0 in 2016, then decreased by 5.49% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
  • Its Amortization - Intangibles was $224000.0 in Q1 2018, compared to $224000.0 in Q4 2017 and $224000.0 in Q3 2017.